QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Erratum An erratum has been published All Versions of this Article: jpet.104.075119v1 312/2/424    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, Y. J. Articles by Neuwelt, E. A. Search for Related Content PubMed PubMed Citation Articles by Wu, Y. J. Articles by Neuwelt, E. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLCYSTEINE CIS-DIAMINEDICHLOROPLATINUM PLATINUM COMPOUNDS

CELLULAR AND MOLECULAR

The Chemoprotective Agent N-Acetylcysteine Blocks Cisplatin-Induced Apoptosis through Caspase Signaling Pathway

Departments of Neurology (Y.J.W., L.L.M., E.A.N.), Neurosurgery (E.A.N.), and Cell and Developmental Biology (L.L.M.), Oregon Health and Sciences University, Portland, Oregon; and Veterans Administration Medical Center, Portland, Oregon (E.A.N.)

Thiols such as N-acetylcysteine (NAC) are increasingly used in clinical trials of platinum chemotherapy as chemoprotectants. NAC can prevent cisdiamminedichloroplatinum (cisplatin)-induced ototoxicity, nephrotoxicity, and gastrointestinal toxicity; however, the molecular mechanisms of NAC on apoptosis and cisplatin cytotoxicity remain unknown. We investigated cisplatin cytotoxicity and NAC chemoprotection in human tumor cell lines, as assessed by immunoblotting and immunocytochemistry. Cisplatin cytotoxicity was associated with nuclear translocation of apoptosis induction factor, expression of the pro-apoptotic Bax protein, cleavage of caspases 3 and 9, and cleavage of PARP. NAC administration reversed the cytotoxic and apoptotic effects if added concurrent with cisplatin or up to 2 h after cisplatin, but chemoprotection was reduced if NAC administration was delayed more than 2 h and was minimal by 8 h after cisplatin. Expression of tumor suppressor p53 and the cell cycle regulatory protein p21 was stimulated within 5 to 10 min by cisplatin in p53-positive LX-1 small cell lung carcinoma cells, and this effect was blocked by NAC. In p53-negative SKOV3 cells, cisplatin toxicity and NAC chemoprotection remained effective, suggesting that chemoprotection may be mediated through both p53-dependent and -independent pathways. Specific kinase inhibitors demonstrated that cisplatin induced apoptosis through the p38 mitogen-activated protein kinase (MAPK) pathway, not the extracellular signal-regulated kinase MAPK pathway. These results show that NAC blocks both the death receptor and the mitochondrial apoptotic pathways induced by cisplatin. The time course for NAC chemoprotection after cisplatin matches our previous in vivo results and provides an opportunity to manipulate route and timing to maintain cisplatin antitumor efficacy while protecting against chemotherapy side effects.

Address correspondence to: Dr. Edward A. Neuwelt, Department of Neurology and Blood Brain Barrier Program, Oregon Health and Sciences University, 3181 Sam Jackson Parkway, L603, Portland, OR 97239. E-mail: neuwelte{at}ohsu.edu

This article has been cited by other articles:

				J. Luo, T. Tsuji, H. Yasuda, Y. Sun, Y. Fujigaki, and A. Hishida The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2198 - 2205. [Abstract] [Full Text] [PDF]

				J. Shao, C. C. White, M. J. Dabrowski, T. J. Kavanagh, M. L. Eckert, and E. P. Gallagher The Role of Mitochondrial and Oxidative Injury in BDE 47 Toxicity to Human Fetal Liver Hematopoietic Stem Cells Toxicol. Sci., January 1, 2008; 101(1): 81 - 90. [Abstract] [Full Text] [PDF]

				L. Wang, P. Chanvorachote, D. Toledo, C. Stehlik, R. R. Mercer, V. Castranova, and Y. Rojanasakul Peroxide Is a Key Mediator of Bcl-2 Down-Regulation and Apoptosis Induction by Cisplatin in Human Lung Cancer Cells Mol. Pharmacol., January 1, 2008; 73(1): 119 - 127. [Abstract] [Full Text] [PDF]

				P. Chanvorachote, U. Nimmannit, C. Stehlik, L. Wang, B.-H. Jiang, B. Ongpipatanakul, and Y. Rojanasakul Nitric Oxide Regulates Cell Sensitivity to Cisplatin-Induced Apoptosis through S-Nitrosylation and Inhibition of Bcl-2 Ubiquitination. Cancer Res., June 15, 2006; 66(12): 6353 - 6360. [Abstract] [Full Text] [PDF]

				J. H. Doroshow Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity. J Natl Cancer Inst, February 15, 2006; 98(4): 223 - 225. [Full Text] [PDF]

				D. T. Dickey, Y. J. Wu, L. L. Muldoon, and E. A. Neuwelt Protection against Cisplatin-Induced Toxicities by N-Acetylcysteine and Sodium Thiosulfate as Assessed at the Molecular, Cellular, and in Vivo Levels J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1052 - 1058. [Abstract] [Full Text] [PDF]